Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione

EU orphan designation number: EU/3/10/802   
Active ingredient: 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: GenKyoTex Innovation S.A.S
Domaine de Chosal, F-74160 Archamps, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/079/10 (2010)8586 of 26/11/2010
02/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/079/10/T/01 (2011)6290 of 30/08/2011